Buy Side Bro

Alphabet Inc. GOOGL

Latest Deep Dive · Written · AI research note

Bro's verdict

Deep Dive

Rating

BUY

Confidence

70%

Target price

$420.00

Upside

▲ 22.0%

Horizon

medium

Alphabet trades at a genuine discount to mega-cap peers on a clean ~21x forward P/E, with 24.6% forward revenue growth, a 34% operating margin, and 49% ROE, while the market prices in AI search disruption and antitrust remedies rather than deteriorating fundamentals. The base case fair value of $410-$425 implies roughly 20% upside, consistent with the $430 consensus, with a benign antitrust outcome the largest re-rating catalyst. Risks are binary and material—particularly an adverse ad tech divestiture that could push the stock toward $300—so conviction is solid but not maximal.

Executive Summary

•Alphabet trades at ~21x clean NTM P/E (EQRV BF P/E 21.1x) versus MSFT at 29.7x and META at 26.6x TTM P/E, a ~25 to 30% discount that prices in AI search disruption and antitrust remedies rather than current fundamentals.
•The headline 54.8% TTM net margin is a data artifact: Q4 net income of $112.11b on $119.80b revenue reflects large one time investment gains, so normalised net income is closer to a ~$140b annual run rate (~31% margin).
•Google Cloud scale up plus external TPU monetisation are the swing value drivers, but the raised 2026 capex guide of $195 to $205b creates a depreciation drag that compresses near term free cash flow even as revenue compounds.
•Antitrust is the binary risk: search default distribution remedies and an ad tech divestiture could each remove material revenue, while the consensus PT of $430 implies ~25% upside if remedies land benignly.

Financial Snapshot

•Revenue (TTM): $445.87b
•Revenue growth (forward NTM): +24.6%
•Gross margin: 60.9%
•Operating margin: 34.0%
•Net margin (TTM): 54.8% (inflated by one time gains)
•Normalised net margin: ~31% (est)
•ROE: 48.7%
•Debt/Equity: 18.9%
•Market cap: $4,105.66b
•Current price: $344.18
•52 week range: $244.15 to $408.61
•Q4 revenue: $119.80b, net income $112.11b (one time gains)
•Q3 revenue: $109.90b, net income $62.58b
•Q2 revenue: $113.83b, net income $34.45b
•Q1 revenue: $102.35b, net income $34.98b

Forward Outlook

•NTM revenue estimate: $498.79b (+24.6% YoY)
•FY+2 revenue estimate: $621.65b
•NTM EPS consensus: $20.59 headline, but the revision trend tracks $16.34 on a cleaner basis
•FY+2 EPS estimate: $15.30, flagged as inconsistent with the $20.59 headline
•NTM EPS revisions: -1.8% over 1 month, a mild negative drift
•2026 capex guide: $195 to $205b, up sharply year over year
•Operating margin expected to hold near 34% despite the capex step up
•Depreciation drag to build through 2026 as prior capex converts to expense

Valuation Analysis

•NTM P/E (headline): 16.71x on $20.59 EPS
•NTM P/E (clean): ~21.1x on $16.34 EPS (EQRV BF P/E), versus 2y average 22.0x
•NTM P/S: 8.44x on $498.79b forward revenue
•NTM EV/EBIT: 7.8x (EQRV), flagged as distorted by one time gains inflating the denominator
•NTM EV/EBITDA: 6.8x (EQRV), same distortion caveat
•TTM P/E: ~16.8x on reported earnings, ~29x on normalised earnings
•EQRV BF EV/Rev 3.2x versus 2y average 5.0x (-36%, -2.1 SD)
•EQRV LF P/BV 6.8x versus 2y average 5.0x (+37%, +1.3 SD)
•MSFT: ~29.7x TTM P/E, $3,961.7b cap, cloud and AI leadership
•META: ~26.6x TTM P/E, $1,797.1b cap, digital ads and AI infra exposure
•AMZN: ~21.1x TTM P/E, $2,830.9b cap, AWS and retail diversification
•Consensus price target: $430.3 (median $425, range $350 to $485)
•Fair value (base case): $410 to $425, ~20% upside
•Bull case: $485 (antitrust clarity plus TPU external sales)
•Bear case: $300 (adverse ad tech divestiture plus AI search monetisation decay)

Key Risks & Catalysts

Risks

•Search default remedy could force changes to distribution deals, pressuring traffic acquisition costs and query share
•Ad tech divestiture of the ad exchange could remove a high margin revenue layer
•Publisher damages exceeding $3.2b add to legal overhang
•AI Overviews and AI Mode may lower paid click monetisation per query as answers replace links
•$195 to $205b capex drives depreciation and free cash flow compression into 2026
•NTM EPS revisions are negative (-1.8% over 1 month)
•Gemini faces intense competition from OpenAI and Anthropic on model quality and enterprise adoption
•13F holders fell 4,962 QoQ and a put/call ratio of 1.80 signals cautious positioning

Catalysts

•External TPU sales (Meta reportedly in talks) would open a high growth silicon revenue stream
•Google Cloud backlog conversion sustaining ~30% growth
•Gemini monetisation via Google One and Workspace subscriptions
•Waymo and Other Bets optionality
•Antitrust remedy clarity removing the valuation overhang
•Continued buyback support at ~21x forward earnings

Investment Thesis

Alphabet is a high quality compounder trading at a genuine discount to mega cap peers, but the discount is narrower than headline screens suggest. The 16.71x NTM P/E rests on a $20.59 EPS figure that appears inflated by one time investment gains, while the cleaner forward multiple is ~21x. Even on that basis Alphabet sits below MSFT and META and roughly in line with AMZN, against 24.6% forward revenue growth and a 34% operating margin. The market is paying for AI search disruption and antitrust risk, not for a deteriorating core.

The two variables that decide the outcome are Cloud and capital intensity. Google Cloud scale up, a large backlog, and external TPU monetisation would lift both growth and margin mix, since owned silicon carries better economics than purchased GPUs. Against that, the $195 to $205b capex guide converts to a rising depreciation charge that will suppress free cash flow through 2026. The question is whether revenue and margin expansion outrun the depreciation drag, and the resilient 34% operating margin suggests it can.

I rate Alphabet a Buy with a base case fair value of $410 to $425, roughly 20% upside and consistent with the $430 consensus. The clean 21x forward multiple offers an attractive entry for a franchise with 49% ROE and a fortress balance sheet. The key monitorables are the antitrust remedy rulings and the pace of Cloud and TPU revenue disclosure; a benign remedy outcome is the single largest re rating catalyst, while an adverse ad tech divestiture is the main downside scenario toward $300.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Run your own analysis free

Buy Side Bro writes a note like this on any US, ASX or global stock in a few minutes: the thesis, valuation, catalysts, risks and a Buy, Hold or Sell call with a 12-month target. It comes with the daily market wrap, live markets, earnings and charts. Sign in and you get 7 days of full access free, no card needed.

Download on the App Store

See the latest research on other stocks